Researcher
Geert Raes
- Keywords (Vrije Universiteit Brussel):Applied biological sciences, biotechnology
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Vrije Universiteit Brussel):Applied immunology, Nuclear imaging, Medical imaging and therapy not elsewhere classified, Inflammation, Innate immunity, Cancer therapy
Affiliations
- Damya Laoui Lab (Research group)
Member
From1 Oct 2022 → Today - Department of Bio-engineering Sciences (Department)
Member
From8 Apr 2019 → Today - Department of Bio-engineering Sciences (Department)
Member
From8 Apr 2019 → Today - Van Ginderachter Lab (Research group)
Member
From1 Jan 2017 → Today - Department of Bio-engineering Sciences (Department)
Member
From1 Mar 2013 → Today - Department of Bio-engineering Sciences (Department)
Member
From1 Mar 2013 → 20 Oct 2022 - Cellular and Molecular Immunology (Research group)
Member
From1 Jan 2000 → 20 Oct 2022 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 1997 → 20 Oct 2022 - Cellular and Molecular Immunology (Research group)
Member
From1 Oct 1993 → Today
Projects
1 - 4 of 4
- IOF Accelerator:Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Oct 2022 → 31 Mar 2024Funding: IOF - technology validation in real environment
- GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Jan 2020 → TodayFunding: IOF - technology validation in real environment, IOF - mandates
- A peripheral blood monocyte gene signature as biomarker for diagnosis of heptatocellular carcinomaFrom1 Jan 2016 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Quantitative Molecular Imaging Platform (Q-MIP)From1 Jun 2014 → 31 May 2019Funding: Hercules - Large scale research infrastructure
Publications
1 - 10 of 59
- In vitro modelling of local gene therapy with IL-15/IL-15Rα and a PD-L1 antagonist in melanoma reveals an interplay between NK cells and CD4+ T cells(2023)
Authors: R M Awad, Y De Vlaeminck, Fien Meeus, T Ertveldt, Katty Zeven, Hannelore Ceuppens, Cleo Goyvaerts, Magali Verdonck, Gustavo Salguero, G Raes, et al.
Pages: 1-13 - Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT(2023)
Authors: Katty Zeven, Timo W M De Groof, Hannelore Ceuppens, R M Awad, T Ertveldt, Wout De Mey, Fien Meeus, G Raes, K Breckpot, Nick Devoogdt
- Phase I Study of [68Ga]Ga-Anti-CD206-sdAb for PET/CT Assessment of Protumorigenic Macrophage Presence in Solid Tumors (MMR Phase I)(2023)
Authors: Odrade Gondry, Catarina Xavier, Laurens Raes, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, K Breckpot, Q Lecocq, Lore Decoster, Christel Fontaine, et al.
Pages: 1378-1384 - Applications of nanobodies in brain diseases(2022)
Authors: Fang Zheng, Yucheng Pang, Luyao Li, Yuxing Pang, Jiaxin Zhang, Xinyi Wang, G Raes
Pages: 1-17 - In vivo Visualization of M2 Macrophages in the Myocardium After Myocardial Infarction (MI) Using 68 Ga-NOTA-Anti-MMR Nb(2022)
Authors: Zohreh Varasteh, Miriam Braeuer, Sarajo Mohanta, Anna-Lena Steinsiek, Andreas Habenicht, Negar Omidvari, Geoffrey J Topping, Christoph Rischpler, Wolfgang A Weber, Hendrik B. Sager, et al.
- Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions(2022)
Authors: Jesús Bravo Melgar, Sofie Deschoemaeker, G Raes, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Damya Laoui, Kim De Veirman
- Development of a kit for 68GA-labeling of single-domain antibody diagnostics for molecular imaging(2022)
Authors: Henri Baudhuin, Tony Lahoutte, G Raes, Catarina Xavier
Number of pages: 188 - Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha(2021)
Authors: Karen De Vlaminck, Ema Romao, Janik Puttemans, Ana Rita Pombo Antunes, Daliya Kancheva, Isabelle Scheyltjens, Jo A Van Ginderachter, Serge Muyldermans, Nick Devoogdt, Kiavash Movahedi, et al.
- Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer(2021)
Authors: Q Lecocq, P Debie, Janik Puttemans, R M Awad, L De Beck, T Ertveldt, Y De Vlaeminck, Cleo Goyvaerts, G Raes, M Keyaerts, et al.
- Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade(2021)
Authors: Q Lecocq, R M Awad, Y De Vlaeminck, Wout De Mey, T Ertveldt, Cleo Goyvaerts, G Raes, Kris Thielemans, M Keyaerts, Nick Devoogdt, et al.
Pages: 1638-1644
Patents
1 - 3 of 3